Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UCB finds buyer for US generics business despite methylphenidate uncertainties

This article was originally published in Scrip

Executive Summary

Belgian pharma company UCB S.A. has finally found a buyer for its US generics business Kremers Urban Pharmaceuticals Inc., after a deal with private equity firms Advent International and Avista Capital Partners fell through last year. Lannett Company Inc. will pay the Belgian firm $1.23bn in cash plus certain contingent payments.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register